Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 371830, 11 pages
http://dx.doi.org/10.5402/2012/371830
Clinical Study

99mTc-DMSA (V) in Evaluation of Osteosarcoma: Comparative Studies with 18F-FDG PET/CT in Detection of Primary and Malignant Lesions

1Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
2Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
3Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, India

Received 28 November 2011; Accepted 2 January 2012

Academic Editors: Y. Akiyama and A. E. Bilsland

Copyright © 2012 G. P. Bandopadhyaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. ACS detailed guide, http://www.cancer.gov/.
  2. T. R. Harrison, “Oncology and hematology,” in Principles of Internal Medicine, vol. 1, McGraw-Hill, New York, NY, USA, 16th edition, 2005. View at Google Scholar
  3. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” CA: A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Schulte, D. Brecht-Krauss, B. Heymer et al., “Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET,” Journal of Nuclear Medicine, vol. 41, no. 10, pp. 1695–1670, 2000. View at Google Scholar · View at Scopus
  5. A. L. Folpe, R. H. Lyles, J. T. Sprouse, E. U. Conrad, and J. F. Eary, “(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma,” Clinical Cancer Research, vol. 6, no. 4, pp. 1279–1287, 2000. View at Google Scholar · View at Scopus
  6. C. Franzius, J. Sciuk, H. E. Daldrup-Link, H. Jürgens, and O. Schober, “FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy,” European Journal of Nuclear Medicine, vol. 27, no. 9, pp. 1305–1311, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Aoki, H. Watanabe, T. Shinozaki et al., “FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions,” Radiology, vol. 219, no. 3, pp. 774–777, 2001. View at Google Scholar · View at Scopus
  8. S. E. M. Clarke, C. R. Lazarus, P. Wright et al., “Penatvalent Tc99m DMSA, 131I- MIBG, Tc99m MDP: an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid,” Journal of Nuclear Medicine, vol. 29, pp. 33–38, 1988. View at Google Scholar
  9. H. Kobayashi, H. Sakahara, M. Hosono et al., “Soft-tissue tumors: diagnosis with Tc99m(V) dimercaptosuccinic acid scintigraphy,” Radiology, vol. 190, no. 1, pp. 277–280, 1994. View at Google Scholar · View at Scopus
  10. A. Zissimopoulos, A. Zanglis, D. Andreopoulos, and N. Baziotis, “The role of Tc99m(V)-DMSA scan as compared to Tc99m-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma,” Hellenic Journal of Nuclear Medicine, vol. 8, no. 3, pp. 162–164, 2005. View at Google Scholar · View at Scopus
  11. C. Franzius, H. E. Daldrup-Link, J. Sciuk et al., “FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT,” Annals of Oncology, vol. 12, no. 4, pp. 479–486, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. T. R. Miller, J. W. Wallis, and R. A. Grothe Jr., “Design and use of PET tomographs: the effect of slice spacing,” Journal of Nuclear Medicine, vol. 31, no. 10, pp. 1732–1739, 1990. View at Google Scholar · View at Scopus
  13. M. B. McCarville, R. Christie, N. C. Daw, S. L. Spunt, and S. C. Kaste, “PET/CT in the evaluation of childhood sarcomas,” American Journal of Roentgenology, vol. 184, no. 4, pp. 1293–1304, 2005. View at Google Scholar · View at Scopus
  14. H. Ohta, K. Endo, t. Fijita et al., “Clinical evaluation of tumor imaging using Tc99m(V)DMSA, a new tumor imaging agent,” Nuclear Medicine Communications, vol. 9, no. 2, pp. 105–116, 1998. View at Google Scholar
  15. A. S. K. Lam, A. G. Kettle, M. J. O'doherty, A. J. Coakley, S. F. Barrington, and P. J. Blower, “Pentavalent Tc99m-DMSA imaging in patients with bone metastases,” Nuclear Medicine Communications, vol. 18, no. 10, pp. 907–914, 1997. View at Google Scholar · View at Scopus
  16. S. E. M. Clarke, C. R. Lazarus, P. Wright et al., “Penatvalent Tc99m DMSA, 131I- MIBG, Tc99m MDP: an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid,” Journal of Nuclear Medicine, vol. 29, pp. 33–38, 1988. View at Google Scholar